Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year.
Two indigenous vaccines by Zydus Cadila and Bharat Biotech have completed phase 1.
India is the manufacturing partner of the vaccine candidate named Covishield, developed jointly by the University of Oxford’s Jenner Institute’s and AstraZeneca. The Pune-based firm, SII, is looking after the trials at 17 trial sites across India.
Besides this, the Russian Direct Investment Fund (RDIF) and Dr. Reddy’s Laboratories Limited, a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of the Sputnik V vaccine in India.